Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 11, 2014
Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer
Robert J Myerson, Benjamin Tan, Steven Hunt, et al.
Cancer Chemotherapy and Pharmacology
|
June 12, 2014
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies
Andrea Wang-Gillam, Nilay Thakkar, A Craig Lockhart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
Cynthia X Ma, Jingqin Luo, Michael Naughton, et al.
Clinical Pharmacology and Therapeutics
|
September 28, 2018
A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)
Sara R Rashkin, Katherina C Chua, Carol Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians
Jeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
The Lancet. Oncology
|
April 6, 2010
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
Rebecca Aft, Michael Naughton, Kathryn Trinkaus, et al.
NPJ Breast Cancer
|
July 20, 2017
Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial
Kerin Adelson, Bhuvaneswari Ramaswamy, Joseph A Sparano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
Cynthia X Ma, Ron Bose, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
International Journal of Radiation Oncology, Biology, Physics
|
March 11, 2014
Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer
Robert J Myerson, Benjamin Tan, Steven Hunt, et al.
Cancer Chemotherapy and Pharmacology
|
June 12, 2014
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignancies
Andrea Wang-Gillam, Nilay Thakkar, A Craig Lockhart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
Cynthia X Ma, Jingqin Luo, Michael Naughton, et al.
Clinical Pharmacology and Therapeutics
|
September 28, 2018
A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)
Sara R Rashkin, Katherina C Chua, Carol Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians
Jeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.
The Lancet. Oncology
|
April 6, 2010
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
Rebecca Aft, Michael Naughton, Kathryn Trinkaus, et al.
NPJ Breast Cancer
|
July 20, 2017
Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial
Kerin Adelson, Bhuvaneswari Ramaswamy, Joseph A Sparano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer
Cynthia X Ma, Ron Bose, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2017
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X Ma, Feng Gao, Jingqin Luo, et al.
Page
of 5